Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market- Snapshot
The global platelet rich plasma & stem cell alopecia treatment market is expected to reach a value of approximately US$ 450.5 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period. Factors such as increase in demand for accurate and prompt treatment of alopecia and advancements in platelet rich plasma and stem cell therapies that have revolutionized the diagnostic science are likely to boost the market. Moreover, a rise in awareness about platelet rich plasma therapies and stem cell therapies is expected to drive the global market during the forecast period. Increased awareness has driven demand for platelet rich plasma therapy & stem cell therapy in the past few years in countries such as Japan, India, Brazil, and Russia and developed regions such as North America and Europe. Additionally, private players are actively promoting the advantages of treatment of alopecia with stem cell therapy across the globe. A rise in the incidence rates of autoimmune hair loss disorders such as alopecia is estimated to boost the platelet rich plasma & stem cell alopecia treatment market. According to the Journal of Clinical, Cosmetic, and Investigational Dermatology, 2015, the lifetime incidence rate of alopecia areata is approximately 2% worldwide. This is expected to propel the market. However, a lack of treatment approval and high cost of alopecia treatment are likely to hinder the growth of platelet rich plasma & stem cell alopecia treatment market.
The global platelet rich plasma & stem cell alopecia treatment market has been segmented based on treatment, indication, end-user, and region. In terms of treatment, the global market has been classified into platelet rich plasma therapies and stem cell therapy. The platelet rich plasma therapies segment held a major market share and is expected to expand at a significant CAGR, owing to the effectiveness of the therapies in the treatment of many types of alopecia. Platelet rich plasma therapies have revolutionized alopecia treatment by reducing costs, treatment duration, and recovery time for patients. The stem cell therapy segment has been further divided into bone marrow and adipose. Based on indication, the global platelet rich plasma & stem cell alopecia treatment market has been divided into androgenic alopecia, congenital alopecia, cicatricial or scarring alopecia, and others. The androgenic alopecia segment holds a key market share as androgenic alopecia is the most common cause of hair loss in both men and women. About 45% men and 35% women develop androgenic alopecia by 60, which is the highest among all the types of alopecia. A study published in the International Journal of Women’s Dermatology in 2019 revealed that the use of PRP to treat androgenic alopecia is promising due to its autologous nature, minimal invasiveness, lack of major side effects, and low cost compared to hair restoration surgery.
In terms of end-user, the global market has been categorized into hospitals, dermatology clinics, and others. The dermatology clinics segment held a major share of the market, followed by the hospital segment, in 2017. This is due to an increase in preference among patients for dermatology clinics where they can avail combined treatment for hair, skin, and nails. Moreover, an increase in incidence of alopecia, rise in access to dermatologists, and surge in awareness about services provided by dermatology clinics are factors attributable to the high market share of the segment. Certain hospitals have diagnostic facilities, including hair & scalp computerized analysis, in-house laboratory, and a number of different treatment options. This is likely to boost the global market, especially in developing regions.
In terms of region, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global platelet rich plasma & stem cell alopecia treatment market, owing to high rate of adoption of advanced products and rise in market penetration of new market entrants with novel technology in the region. Moreover, high prevalence of alopecia in the region is imposing a significant economic burden and is boosting demand for affordable care. This, in turn, is driving demand for platelet rich plasma & stem cell alopecia treatment. According to the National Institute of Health in 2015, 95% of women suffer from androgenetic alopecia in the U.S.. This has led the country to dominate the platelet rich plasma & stem cell alopecia treatment market in North America. The U.S. is anticipated to maintain its leading position in the market in the region during the forecast period. Additionally, increased application of PRP for the treatment of alopecia has been observed in the past few years. This is likely to fuel the market in the region. The market in Asia Pacific is projected to expand at a significantly high CAGR during the forecast period, owing to the emergence of strong local manufacturers offering various technological advancements for platelet rich plasma & stem cell alopecia treatment at lower prices and increase in awareness among people about these treatment methods. Furthermore, an increase in health care expenditure and investments by key players in emerging regions such as China and India are estimated to fuel the market in the region.
Major players operating in the global platelet rich plasma & stem cell alopecia treatment market include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy. Key players are focused on research & development of alopecia treatment by investing in platelet rich plasma & stem cell alopecia therapies. Mergers & acquisitions, collaborations, and partnerships are helping companies expand their footprint and further develop effective treatments for alopecia.
Rising Adoption of Novel Treatments Drives Platelet Rich Plasma and Stem Cell Alopecia Treatment Market
Stem cell and platelet rich plasma alopecia therapies are classified as biomedicine or regenerative therapy options. Their minimally invasive nature diminishes the need for undergoing surgery and hence are preferred by an increasing number of healthcare and medical professionals and patients suffering from alopecia. Therapies in platelet rich plasma and stem cell alopecia market are aimed at stimulating, strengthening, and rebuilding the hair regrowth in patients. These characteristics make them lucrative for patients as the traditional treatment options, including surgeries consisted of surgically removing damaged scalp tissues. Emergence of novel therapies has created an influx of demand in platelet rich plasma and stem cell alopecia market. They are increasingly being preferred by patients and practicing dermatologists as a sustainable alternative for traditional drugs such as corticosteroids. These novel treatment solutions aim at more effective, faster, and efficient hair regrowth as compared to corticosteroid therapies. They also display admirable ease of administration, which makes them an attractive solution in platelet rich plasma and stem cell alopecia market in coming years.
Manufacturers and prominent players in platelet rich plasma and stem cell alopecia market are focused on undertaking mergers and acquisitions as strategies for enhancing their product offerings and enter newer regional markets. They are aiming at making their treatment therapies more effective and cost efficient to cate to demand from larger consumer base. Players in the global platelet rich plasma and stem cell alopecia market are also forming collaborative and strategic partnerships with suppliers and local manufacturers to expand their business operations and product portfolio. For example, Myungmoon Bio Co., Ltd., a health care company based in South Korea signed a partnership agreement with Kerastem in 2019. This collaboration was aimed at developing new and innovative regenerative therapies for alopecia. Manufacturers and players in platelet rich plasma and stem cell alopecia market are also engaging in collaborations with various contract research organizations (CROs) to develop and manufacture innovative new products. For example, Stemcell technologies Inc., has increasingly focused on partnering with research organizations and institutions to develop advanced therapeutic products in platelet rich plasma and stem cell alopecia market.
The global platelet rich plasma & stem cell alopecia treatment market has been segmented as below:
|
Treatment |
|
|
Indication |
|
|
End-user |
|
|
Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Analysis of Treatments for Alopecia: Overview
5.2. Top Treatment Center Analysis, by Region
5.3. Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Pipeline Analysis - 2018
6. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment, 2016–2026
6.3.1. Platelet Rich Plasma Therapies
6.3.2. Stem Cell Therapy
6.3.2.1. Bone Marrow
6.3.2.2. Adipose
6.4. Market Attractiveness, by Treatment
7. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2016–2026
7.3.1. Androgenic Alopecia
7.3.2. Congenital Alopecia
7.3.3. Cicatricial or Scarring Alopecia
7.3.4. Others
7.4. Market Attractiveness, by Indication
8. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment, 2016–2026
10.2.1. Platelet Rich Plasma Therapies
10.2.2. Stem Cell Therapy
10.2.2.1. Bone Marrow
10.2.2.2. Adipose
10.3. Market Value Forecast, by Indication, 2016–2026
10.3.1. Androgenic Alopecia
10.3.2. Congenital Alopecia
10.3.3. Cicatricial or Scarring Alopecia
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment, 2016–2026
11.2.1. Platelet rich plasma therapies
11.2.2. Stem Cell Therapy
11.2.2.1. Bone Marrow
11.2.2.2. Adipose
11.3. Market Value Forecast, by Indication, 2016–2026
11.3.1. Androgenic Alopecia
11.3.2. Congenital Alopecia
11.3.3. Cicatricial or Scarring Alopecia
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment, 2016–2026
12.2.1. Platelet rich plasma therapies
12.2.2. Stem Cell Therapy
12.2.2.1. Bone Marrow
12.2.2.2. Adipose
12.3. Market Value Forecast, by Indication, 2016–2026
12.3.1. Androgenic Alopecia
12.3.2. Congenital Alopecia
12.3.3. Cicatricial or Scarring Alopecia
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Austalia & New Zearland
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country
13. Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment, 2016–2026
13.2.1. Platelet rich plasma therapies
13.2.2. Stem Cell Therapy
13.2.2.1. Bone Marrow
13.2.2.2. Adipose
13.3. Market Value Forecast, by Indication, 2016–2026
13.3.1. Androgenic Alopecia
13.3.2. Congenital Alopecia
13.3.3. Cicatricial or Scarring Alopecia
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
3.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment, 2016–2026
14.2.1. Platelet rich plasma therapies
14.2.2. Stem Cell Therapy
14.2.2.1. Bone Marrow
14.2.2.2. Adipose
14.3. Market Value Forecast, by Indication, 2016–2026
14.3.1. Androgenic Alopecia
14.3.2. Congenital Alopecia
14.3.3. Cicatricial or Scarring Alopecia
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospitals
14.4.2. Dermatology Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Heat Map Analysis, by Company (2017)
15.3. Company Profiles
15.3.1. Kerastem
15.3.2. Eclipse
15.3.3. Regen Lab SA
15.3.4. Restore Hair
15.3.5. Replicel LifeScience
15.3.6. Histogen Inc.
15.3.7. Glofinn Oy
List of Tables
Table 01: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 02: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Value (US$ Mn) Forecast, Treatment (Stem Cell Therapy), 2016–2026
Table 03: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 04: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 08: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 09: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 10: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 13: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 14: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 15: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 18: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 19: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 20: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 23: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 25: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Treatment, 2016–2026
Table 28: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment for Stem Cell Therapy Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 29: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 30: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Global Plasma Rich Platelet & Stem Cell Alopecia Treatment Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Market Snapshot of Global Plasma Rich Platelet & Stem Cell Alopecia Treatment Market
Figure 03: Market Opportunity Map, Revenue Share, by Treatment
Figure 04: Market Opportunity Map, Revenue Share, by Indication
Figure 05: Market Opportunity Map, Revenue Share, by End-user
Figure 06: Global Plasma Rich Platelet & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 07: Market Value Share, by Treatment, 2017
Figure 08: Market Value Share, by Indication, 2017
Figure 09: Market Value Share, by Region, 2017
Figure 10: Market Value Share, by End-user, 2017
Figure 11: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share Analysis, by Treatment, 2017 and 2026
Figure 12: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Platelet Rich Plasma Therapies, 2016–2026
Figure 13: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Stem Cell Therapy, 2016–2026
Figure 14: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 15: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share Analysis, by Indication, 2017 and 2026
Figure 16: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Androgenic Alopecia, 2016–2026
Figure 17: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Congenital Alopecia, 2016–2026
Figure 18: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cicatricial or Scarring Alopecia, 2016–2026
Figure 19: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 20: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 21: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share Analysis, by End-user, 2017 and 2026
Figure 22: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2016–2026
Figure 23: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dermatology Clinics, 2016–2026
Figure 24: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 25: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
Figure 26: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Region, 2017 and 2026
Figure 27: Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Region, 2018–2026
Figure 28: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 29: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Country, 2017 and 2026
Figure 30: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Country, 2018–2026
Figure 31: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Treatment, 2017 and 2026
Figure 32: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 33: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Indication, 2017 and 2026
Figure 34: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 35: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by End-user, 2017 and 2026
Figure 36: North America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
Figure 37: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 38: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 39: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 40: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Treatment, 2017 and 2026
Figure 41: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 42: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Indication, 2017 and 2026
Figure 43: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 44: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by End-user, 2017 and 2026
Figure 45: Europe Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
Figure 46: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 47: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 48: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 49: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Treatment, 2017 and 2026
Figure 50: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 51: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Indication, 2017 and 2026
Figure 52: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 53: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by End-user, 2017 and 2026
Figure 54: Asia Pacific Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
Figure 55: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 56: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 57: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 58: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Treatment, 2017 and 2026
Figure 59: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 60: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Indication, 2017 and 2026
Figure 61: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 62: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by End-user, 2017 and 2026
Figure 63: Latin America Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
Figure 64: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 65: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 66: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 67: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Treatment, 2017 and 2026
Figure 68: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Treatment, 2018–2026
Figure 69: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by Indication, 2017 and 2026
Figure 70: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by Indication, 2018–2026
Figure 71: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Value Share (%), by End-user, 2017 and 2026
Figure 72: Middle East & Africa Platelet Rich Plasma & Stem Cell Alopecia Treatment Market Attractiveness, by End-user, 2018–2026
